Immunovaccine Announces Results of 2014 Annual General Meeting
April 24, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 24, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today announced the results of...
Immunovaccine's DepoVax(TM) Technology Underpins New Experimental Therapy for Cervical, Head and Neck Cancers
April 08, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 8, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today announced that its...
Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AACR Annual Meeting
April 07, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 7, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, presented positive data from...
Immunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual Meeting
April 03, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - April 3, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today announced that data from...
Immunovaccine and Pfenex Report Positive Results from Single Dose Anthrax Vaccine Studies
April 01, 2014 08:05 ET
|
Immunovaccine Inc.;Pfenex Inc.
HALIFAX, NOVA SCOTIA and SAN DIEGO, CALIFORNIA--(Marketwired - April 1, 2014) - Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE:IMV) and Pfenex Inc. ("Pfenex") today announced positive...
Immunovaccine Announces 2013 Year-End Results
March 17, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - March 17, 2014) - Immunovaccine Inc. (TSX VENTURE:IMV), a clinical stage vaccine company, today announced its financial and operational results for the year...
Llew Keltner, US Biotech Industry Adviser, Joins Board of Immunovaccine
January 20, 2014 08:07 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Grants Stock Options
January 20, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 6th Annual Biotech Showcase Conference
January 09, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 9, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors
December 16, 2013 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 16, 2013) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...